Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
Abstract Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would –...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Cardiovascular Diabetology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12933-024-02550-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823863312752836608 |
|---|---|
| author | Katharine Barnard-Kelly Tadej Battelino Frank C. Brosius Antonio Ceriello Francesco Cosentino James R. Gavin Francesco Giorgino Jennifer Green Linong Ji Monika Kellerer Sue Koob Mikhail Kosiborod Nebojsa Lalic Nikolaus Marx Prashant Nedungadi Christopher G. Parkin Helena W. Rodbard René D. Rötzer Lars Rydén Wayne Huey-Herng Sheu Eberhard Standl Britta Tendal Jeppesen Pinar Topsever Per Olav Vandvik Christoph Wanner Oliver Schnell |
| author_facet | Katharine Barnard-Kelly Tadej Battelino Frank C. Brosius Antonio Ceriello Francesco Cosentino James R. Gavin Francesco Giorgino Jennifer Green Linong Ji Monika Kellerer Sue Koob Mikhail Kosiborod Nebojsa Lalic Nikolaus Marx Prashant Nedungadi Christopher G. Parkin Helena W. Rodbard René D. Rötzer Lars Rydén Wayne Huey-Herng Sheu Eberhard Standl Britta Tendal Jeppesen Pinar Topsever Per Olav Vandvik Christoph Wanner Oliver Schnell |
| author_sort | Katharine Barnard-Kelly |
| collection | DOAJ |
| description | Abstract Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would – dependent on the topic of guideline – be important for improving shared decision-making, patients’ concordance with guideline recommendations, clinical outcomes and health-related quality of life (HRQoL). The Taskforce of the Guideline Workshop discussed PROs in diabetes, obesity, CVD and CKD as well as the relevance of their inclusion in clinical practice guidelines for the management of these conditions. |
| format | Article |
| id | doaj-art-df1d30999df7480799493c44795ea97f |
| institution | Kabale University |
| issn | 1475-2840 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | BMC |
| record_format | Article |
| series | Cardiovascular Diabetology |
| spelling | doaj-art-df1d30999df7480799493c44795ea97f2025-02-09T12:10:52ZengBMCCardiovascular Diabetology1475-28402025-02-0124111210.1186/s12933-024-02550-2Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline WorkshopKatharine Barnard-Kelly0Tadej Battelino1Frank C. Brosius2Antonio Ceriello3Francesco Cosentino4James R. Gavin5Francesco Giorgino6Jennifer Green7Linong Ji8Monika Kellerer9Sue Koob10Mikhail Kosiborod11Nebojsa Lalic12Nikolaus Marx13Prashant Nedungadi14Christopher G. Parkin15Helena W. Rodbard16René D. Rötzer17Lars Rydén18Wayne Huey-Herng Sheu19Eberhard Standl20Britta Tendal Jeppesen21Pinar Topsever22Per Olav Vandvik23Christoph Wanner24Oliver Schnell25Southern Health NHS Foundation TrustUniversity Medical CenterUniversity of Arizona College of MedicineIRCCS MultiMedicaCardiology Unit, Department of Medicine, Karolinska Institute, Karolinska University HospitalEmory University School of MedicineDepartment of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo MoroDuke University Medical Center, Duke Clinical Research InstitutePeking University People’s HospitalMarienhospital StuttgartPCNA National OfficeSaint Luke’s Mid America Heart Institute and University of Missouri-Kansas CityUniversity Clinical Center of Serbia, University of BelgradeDepartment of Internal Medicine I, University Hospital Aachen, RWTH Aachen UniversityAmerican Heart AssociationCGParkin Communications, Inc.Endocrine and Metabolic ConsultantsSciarc GmbHDepartment of Medicine K2, Karolinska InstituteInstitute of Molecular and Genomic Medicine, National Research Health InstitutesForschergruppe Diabetes e. V, Helmholtz Center MunichFuture Evidence FoundationDepartment of Family Medicine, Acıbadem Mehmet Ali Aydınlar University School of MedicineDepartment of Medicine, Lovisenberg Diaconal Hospital, Institute of Health and Society, University of OsloDepartment of Internal Medicine I, Universitätsklinikum WürzburgForschergruppe Diabetes e. V, Helmholtz Center MunichAbstract Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the assessment of patient-reported outcomes (PROs), which would – dependent on the topic of guideline – be important for improving shared decision-making, patients’ concordance with guideline recommendations, clinical outcomes and health-related quality of life (HRQoL). The Taskforce of the Guideline Workshop discussed PROs in diabetes, obesity, CVD and CKD as well as the relevance of their inclusion in clinical practice guidelines for the management of these conditions.https://doi.org/10.1186/s12933-024-02550-2Cardiovascular diseaseChronic kidney diseaseDiabetesObesityPerson-reported outcomes |
| spellingShingle | Katharine Barnard-Kelly Tadej Battelino Frank C. Brosius Antonio Ceriello Francesco Cosentino James R. Gavin Francesco Giorgino Jennifer Green Linong Ji Monika Kellerer Sue Koob Mikhail Kosiborod Nebojsa Lalic Nikolaus Marx Prashant Nedungadi Christopher G. Parkin Helena W. Rodbard René D. Rötzer Lars Rydén Wayne Huey-Herng Sheu Eberhard Standl Britta Tendal Jeppesen Pinar Topsever Per Olav Vandvik Christoph Wanner Oliver Schnell Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop Cardiovascular Diabetology Cardiovascular disease Chronic kidney disease Diabetes Obesity Person-reported outcomes |
| title | Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop |
| title_full | Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop |
| title_fullStr | Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop |
| title_full_unstemmed | Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop |
| title_short | Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop |
| title_sort | defining patient reported outcomes in diabetes obesity cardiovascular disease and chronic kidney disease for clinical practice guidelines perspectives of the taskforce of the guideline workshop |
| topic | Cardiovascular disease Chronic kidney disease Diabetes Obesity Person-reported outcomes |
| url | https://doi.org/10.1186/s12933-024-02550-2 |
| work_keys_str_mv | AT katharinebarnardkelly definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT tadejbattelino definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT frankcbrosius definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT antonioceriello definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT francescocosentino definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT jamesrgavin definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT francescogiorgino definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT jennifergreen definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT linongji definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT monikakellerer definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT suekoob definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT mikhailkosiborod definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT nebojsalalic definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT nikolausmarx definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT prashantnedungadi definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT christophergparkin definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT helenawrodbard definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT renedrotzer definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT larsryden definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT waynehueyherngsheu definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT eberhardstandl definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT brittatendaljeppesen definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT pinartopsever definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT perolavvandvik definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT christophwanner definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop AT oliverschnell definingpatientreportedoutcomesindiabetesobesitycardiovasculardiseaseandchronickidneydiseaseforclinicalpracticeguidelinesperspectivesofthetaskforceoftheguidelineworkshop |